Our prior research has established that sustained PGC-1α expression is critical for mitigating AD-like cognitive impairments and neuronal apoptosis (Shi et al., 2024; Wang et al., 2021, 2022a). This evidence concerns the gene PPARGC1A and Alzheimer disease.